North China Pharmaceutical Company. Ltd

Short Term Long Term Short Term Comparison Long Term Comparison
  • 600812
  • 1d-2.37%
  • 1w-2.99%
  • 1m-7.72%
  • 1y-26.66%
ATH
  • ATH Price$18.60
  • ATH Date2020-08-06
  • % since ATH-75.60%
  • % to ATH309.77%
ATL
  • ATL Price$1.04
  • ATL Date2005-07-11
  • % from ATL334.57%
  • Last Low Price$3.98
  • Last Low Date2024-02-05
  • % From Last Low14.07%
IPO
  • IPO Price$3.44
  • % Current ROI USD131.98%
  • ATH Price$18.60
  • % ROI ATH 178,076.96%
[addtoany]

Graph takes few seconds to load...

[financial_chart symbol="600812"]

Key Data [addtoany]

Current price $4.54
Sector Healthcare
Industry Drug Manufacturers - Specialty & Generic
Today's High/Low $4.71/$4.5
Volume 13,334,470.00
Previous Close $4.65
52 Week High/Low $6.66/$3.83
Market Cap 7,875,201,024.00
P/E Ratio 0
Forward P/E 1 Yr. $0.00
Earnings Per Share(EPS) $0
Annualized Dividend $0
$4.54
[addtoany]

North China Pharmaceutical Company Ltd. operates as a chemical pharmaceutical company in China. It primarily offers anti-infective drugs, comprising APIs, and intermediates and their preparations; biotechnology drugs; cardiovascular and immunomodulators, and other therapeutic drugs; vitamins and nutraceuticals; and bio-agricultural and veterinary drugs.
The company was founded in 1953 and is based in Shijiazhuang, China.

Annual Data | Millions of US $ except per share data
Cash on hand
Receivables
Inventory
Pre-Paid Expenses
Other Current Assets
Total Current Assets
Property, Plant, And Equipment
Long-Term Investments
Goodwill And Intangible Assets
Other Long-Term Assets
Total Long-Term Assets
Total Assets
Total Current Liabilities
Long Term Debt
Other Non-Current Liabilities
Total Long Term Liabilities
Total Liabilities
Common Stock Net
Retained Earnings (Accumulated Deficit)
Comprehensive Income
Other Share Holders Equity
Share Holder Equity
Total Liabilities And Share Holders Equity